TY  - CHAP
M1  - Book, Section
TI  - Margetuximab-cmkb (Margenza) Approved for Treatment of Metastatic HER2-Positive Breast Cancer
A1  - Peh, Keng Hee
A1  - Kolesar, Jill M.
Y1  - 2020
N1  - 
T2  - PPP Updates
AB  - 
SN  - 
PB  - McGraw Hill
CY  - New York, NY
Y2  - 2024/04/23
UR  - ppp.mhmedical.com/updatesContent.aspx?gbosid=556586
ER  -